Stoke Therapeutics (STOK) Financials: Revenue & Earnings
STOK$26.25+0.12 +0.46%
$1.69B
Market Cap
-7.35
P/E
12.26
Forward P/E
51
Score
Stoke Therapeutics (STOK) Financials: Revenue & Earnings
STOK price $26.25 +0.12 +0.46%
- Ticker
- STOK
- Price
- $26.25
- Change
- +0.12 +0.46%
- Market cap ?
- $1.69B
- P/E ?
- -7.35
- Forward P/E ?
- 12.26
- Dividend yield ?
- 0.00%
- Beta ?
- 1.26
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 51
- Value
- 56
- Quality
- 48
- Growth
- 50
Stocklytics score rationale: value 56, quality 48, growth 50.
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 12405000 | 8780000 | 36555000 | 184420000 |
Stoke Therapeutics, Inc. is an emerging biopharmaceutical company dedicated to developing innovative antisense oligonucleotide (ASO) therapies. Its primary focus is to target and address the fundamental causes of severe genetic disorders, particularly within the United States. The company employs its exclusive Targeted Augmentation of Nuclear Gene Output (TANGO) platform to engineer ASOs that precisely enhance…
Fair value
STOK fair value $45.60. Price $26.25. Price is 42% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 37.48M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 11.24% (beta 1.3). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 64.53M. Net debt -81.21M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-29 | — | -0.93 | — | 8.21M |
| 2026-08-03 | -0.93 | -0.80 | 9.32M | 4.89M |
| 2026-05-07 | -0.79 | -0.80 | 6.23M | 6.48M |
| 2026-03-16 | -0.97 | -0.75 | 1.40M | 5.83M |
| 2025-11-04 | -0.65 | -0.54 | 10.63M | 4.56M |
| 2025-08-12 | -0.40 | -0.57 | 13.82M | 5.36M |
| 2025-05-13 | 1.90 | -0.37 | 158.57M | 31.51M |
| 2025-03-18 | -0.18 | -0.51 | 22.61M | 3.86M |
| 2024-11-05 | -0.47 | -0.52 | 4.89M | 4.20M |
| 2024-08-07 | -0.46 | -0.57 | 4.83M | 3.26M |
| 2024-05-06 | -0.57 | -0.60 | 4.22M | 3.21M |
| 2024-03-25 | -0.60 | -0.62 | 2.80M | 3.25M |
| 2023-11-07 | -0.55 | -0.65 | 3.31M | 3.25M |
| 2023-08-07 | -0.69 | -0.65 | 2.48M | 3.17M |
| 2023-05-04 | -0.53 | -0.70 | 5.15M | 3.00M |
| 2023-03-06 | -0.65 | -0.72 | 3.27M | 2.86M |
| 2022-11-14 | -0.66 | -0.69 | 2.90M | 2.72M |
| 2022-08-08 | -0.63 | -0.70 | 3.23M | 2.64M |
| 2022-05-10 | -0.66 | 0.61 | 3.00M | 50.00M |
| 2022-03-10 | -0.66 | -0.62 | — | — |
| 2021-11-08 | -0.61 | -0.58 | — | — |
| 2021-08-10 | -0.60 | -0.49 | — | — |
| 2021-05-10 | -0.46 | -0.44 | — | — |
| 2021-03-09 | -0.42 | -0.43 | — | — |
| 2020-11-12 | -0.41 | -0.42 | — | — |
| 2020-08-10 | -0.39 | -0.36 | — | — |
| 2020-05-15 | -0.34 | -0.37 | — | — |
| 2020-02-24 | -0.09 | -0.31 | — | — |
| 2019-11-12 | -0.26 | -0.29 | — | — |
| 2019-08-14 | -1.54 | -0.96 | — | — |
| 2019-06-19 | -0.18 | — | — | — |
| 2019-03-31 | -0.19 | — | — | — |
| 2018-09-30 | -0.14 | — | — | — |
| 2018-06-30 | -0.13 | — | — | — |
| 2018-03-31 | -0.08 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Allan Jonathan | Sell | 627 | $26.33 | 16.51K |
| 2026-10-01 | Ticho Barry | Sell | 1.05K | $26.16 | 27.49K |
| 2026-09-23 | Cumbo Alexander | Buy | 39.67K | $26.11 | 1.04M |
| 2026-09-23 | Cumbo Alexander | Other | 0 | — | — |
| 2026-09-01 | Ticho Barry | Sell | 3.94K | $30.51 | 120.37K |
| 2026-09-01 | Ticho Barry | Sell | 1.60K | $31.06 | 49.69K |
| 2026-08-18 | Ticho Barry | Sell | 4.53K | $32.01 | 144.83K |
| 2026-08-18 | Ticho Barry | Sell | 242 | $32.47 | 7.86K |
| 2026-08-18 | Kaye Edward M. MD | Sell | 11.93K | $32.01 | 381.85K |
| 2026-08-18 | Kaye Edward M. MD | Sell | 637 | $32.47 | 20.68K |
| 2026-08-18 | Allan Jonathan | Sell | 2.72K | $32.01 | 86.93K |
| 2026-08-18 | Allan Jonathan | Sell | 145 | $32.47 | 4.71K |
| 2026-08-14 | Ticho Barry | Buy | 10.00K | — | — |
| 2026-08-14 | Ticho Barry | Sell | 10.00K | — | — |
| 2026-08-14 | Kaye Edward M. MD | Buy | 26.25K | — | — |
| 2026-08-14 | Kaye Edward M. MD | Sell | 26.25K | — | — |
| 2026-08-14 | Allan Jonathan | Buy | 6.00K | — | — |
| 2026-08-14 | Allan Jonathan | Sell | 6.00K | — | — |
| 2026-08-03 | Ticho Barry | Sell | 5.91K | $28.95 | 171.01K |
| 2026-08-03 | Ticho Barry | Sell | 1.27K | $29.45 | 37.38K |
| 2026-07-16 | Harrison Seth Loring | Buy | 29.75K | $10.90 | 324.24K |
| 2026-07-16 | Harrison Seth Loring | Buy | 29.55K | $28.80 | 851.18K |
| 2026-07-16 | Harrison Seth Loring | Buy | 21.00K | $12.96 | 272.16K |
| 2026-07-16 | Harrison Seth Loring | Buy | 19.44K | $12.46 | 242.23K |
| 2026-07-16 | Harrison Seth Loring | Buy | 17.79K | $29.46 | 523.98K |
| 2026-07-16 | Harrison Seth Loring | Buy | 14.78K | $26.53 | 392.03K |
| 2026-07-16 | Harrison Seth Loring | Buy | 11.65K | $40.37 | 470.31K |
| 2026-07-16 | Harrison Seth Loring | Buy | 7.64K | $16.41 | 125.36K |
| 2026-07-16 | Harrison Seth Loring | Sell | 19.44K | $12.46 | 242.23K |
| 2026-07-16 | Harrison Seth Loring | Sell | 11.65K | $40.37 | 470.31K |
| 2026-07-16 | Harrison Seth Loring | Sell | 7.64K | $16.41 | 125.36K |
| 2026-07-16 | Harrison Seth Loring | Sell | 29.75K | $10.90 | 324.24K |
| 2026-07-16 | Harrison Seth Loring | Sell | 29.55K | $28.80 | 851.18K |
| 2026-07-16 | Harrison Seth Loring | Sell | 17.79K | $29.46 | 523.98K |
| 2026-07-16 | Harrison Seth Loring | Sell | 14.78K | $26.53 | 392.03K |
| 2026-07-16 | Harrison Seth Loring | Sell | 21.00K | $12.96 | 272.16K |
| 2026-07-15 | McCauley Thomas | Buy | 225.00K | $29.91 | 6.73M |
| 2026-07-13 | McCauley Thomas | Other | 0 | — | — |
| 2026-07-01 | Ticho Barry | Sell | 6.73K | $32.62 | 219.43K |
| 2026-07-01 | Ticho Barry | Sell | 500 | $33.27 | 16.63K |
| 2026-06-16 | Allan Jonathan | Sell | 1.46K | $29.95 | 43.64K |
| 2026-06-03 | TZIANABOS ARTHUR | Buy | 17.79K | $29.46 | 523.98K |
| 2026-06-03 | Smith Julie | Buy | 17.79K | $29.46 | 523.98K |
| 2026-06-03 | LEVIN ARTHUR A | Buy | 17.79K | $29.46 | 523.98K |
| 2026-06-03 | Krainer Adrian R. | Buy | 17.79K | $29.46 | 523.98K |
| 2026-06-03 | Kaye Edward M. MD | Buy | 17.79K | $29.46 | 523.98K |
| 2026-06-03 | Harrison Seth Loring | Buy | 17.79K | $29.46 | 523.98K |
| 2026-06-03 | Burstein Jennifer | Buy | 17.79K | $29.46 | 523.98K |
| 2026-06-01 | Ticho Barry | Sell | 1.79K | $30.58 | 54.89K |
| 2026-05-01 | Ticho Barry | Sell | 2.24K | $32.79 | 73.55K |
| 2026-04-03 | Kahn Clare | Buy | 30.78K | $32.79 | 1.01M |
| 2026-04-03 | Kahn Clare | Other | 0 | — | — |
| 2026-04-01 | Ticho Barry | Sell | 1.84K | $32.66 | 60.03K |
| 2026-03-20 | Allan Jonathan | Sell | 8.69K | $33.64 | 292.36K |
| 2026-03-20 | Allan Jonathan | Sell | 601 | $34.41 | 20.68K |
| 2026-03-19 | Ticho Barry | Sell | 1.36K | $2.19 | 2.99K |
| 2026-03-19 | Ticho Barry | Buy | 1.36K | $2.19 | 2.99K |
| 2026-03-19 | Ticho Barry | Sell | 1.46K | $29.99 | 43.82K |
| 2026-03-18 | Ticho Barry | Sell | 6.10K | $31.28 | 190.83K |
| 2026-03-18 | Ticho Barry | Sell | 483 | $31.79 | 15.35K |
| 2026-03-18 | Ticho Barry | Sell | 103 | $32.85 | 3.38K |
| 2026-03-18 | Leggett Thomas | Sell | 2.17K | $31.28 | 67.98K |
| 2026-03-18 | Leggett Thomas | Sell | 172 | $31.79 | 5.47K |
| 2026-03-18 | Leggett Thomas | Sell | 37 | $32.85 | 1.22K |
| 2026-03-18 | Hoitt Jason | Sell | 1.76K | $31.28 | 55.12K |
| 2026-03-18 | Hoitt Jason | Sell | 139 | $31.79 | 4.42K |
| 2026-03-18 | Hoitt Jason | Sell | 30 | $32.85 | 986 |
| 2026-03-18 | Allan Jonathan | Sell | 4.22K | $31.28 | 132.08K |
| 2026-03-18 | Allan Jonathan | Sell | 334 | $31.79 | 10.62K |
| 2026-03-18 | Allan Jonathan | Sell | 72 | $32.85 | 2.37K |
| 2026-03-17 | Ticho Barry | Sell | 3.58K | $32.74 | 117.11K |
| 2026-03-17 | Ticho Barry | Sell | 2.59K | $33.38 | 86.34K |
| 2026-03-17 | Leggett Thomas | Sell | 1.27K | $32.74 | 41.71K |
| 2026-03-17 | Leggett Thomas | Sell | 922 | $33.38 | 30.77K |
| 2026-03-17 | Hoitt Jason | Sell | 1.03K | $32.74 | 33.82K |
| 2026-03-17 | Hoitt Jason | Sell | 748 | $33.38 | 24.96K |
| 2026-03-17 | Allan Jonathan | Sell | 2.48K | $32.74 | 81.06K |
| 2026-03-17 | Allan Jonathan | Sell | 1.79K | $33.38 | 59.78K |
| 2026-03-15 | Hoitt Jason | Sell | 10.00K | — | — |
| 2026-03-15 | Hoitt Jason | Buy | 10.00K | — | — |
| 2026-03-15 | Leggett Thomas | Sell | 14.75K | — | — |
| 2026-03-15 | Leggett Thomas | Buy | 14.75K | — | — |
| 2026-03-15 | Ticho Barry | Buy | 10.75K | — | — |
| 2026-03-15 | Ticho Barry | Buy | 10.00K | — | — |
| 2026-03-15 | Ticho Barry | Buy | 13.10K | — | — |
| 2026-03-15 | Ticho Barry | Sell | 10.75K | — | — |
| 2026-03-15 | Ticho Barry | Sell | 10.00K | — | — |
| 2026-03-15 | Ticho Barry | Sell | 13.10K | — | — |
| 2026-03-15 | Kaye Edward M. MD | Buy | 26.25K | — | — |
| 2026-03-15 | Kaye Edward M. MD | Buy | 35.50K | — | — |
| 2026-03-15 | Kaye Edward M. MD | Sell | 26.25K | — | — |
| 2026-03-15 | Kaye Edward M. MD | Sell | 35.50K | — | — |
| 2026-03-15 | Allan Jonathan | Buy | 12.00K | — | — |
| 2026-03-15 | Allan Jonathan | Sell | 12.00K | — | — |
| 2026-03-15 | Allan Jonathan | Buy | 6.00K | — | — |
| 2026-03-15 | Allan Jonathan | Buy | 7.47K | — | — |
| 2026-03-15 | Allan Jonathan | Sell | 6.00K | — | — |
| 2026-03-15 | Allan Jonathan | Sell | 7.47K | — | — |
| 2026-03-13 | LEVIN ARTHUR A | Sell | 605 | $36.80 | 22.26K |
| 2026-03-10 | TZIANABOS ARTHUR | Sell | 3.96K | $8.33 | 32.95K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 203, holders -3 vs prior quarter. Ownership 121.65%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 5.88M | 491.64K | +9.13% | 192.31M |
| RTW INVESTMENTS, LP | 5.62M | 0 | 0.00% | 184.00M |
| FMR LLC | 5.31M | -70.57K | -1.31% | 173.84M |
| LYNX1 CAPITAL MANAGEMENT LP | 4.04M | -725.27K | -15.22% | 132.14M |
| REDMILE GROUP, LLC | 3.95M | -218.20K | -5.24% | 129.11M |
| WELLINGTON MANAGEMENT GROUP LLP | 3.52M | 423.60K | +13.68% | 115.15M |
| MORGAN STANLEY | 3.45M | 29.52K | +0.86% | 112.98M |
| BAKER BROS. ADVISORS LP | 3.34M | 0 | 0.00% | 109.18M |
| TORONTO DOMINION BANK | 3.17M | 0 | 0.00% | 103.83M |
| STATE STREET CORP | 2.85M | 575.73K | +25.29% | 93.33M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.66M | 727.57K | +37.62% | 87.09M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.59M | 231.33K | +9.82% | 84.64M |
| BVF INC/IL | 2.55M | 0 | 0.00% | 83.36M |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.42M | 2.16M | +862.54% | 79.02M |
| SIREN, L.L.C. | 2.00M | 0 | 0.00% | 65.29M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.82M | 0 | 0.00% | 59.66M |
| JUPITER TOPCO LLC | 1.81M | 1.81M | New | 59.36M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.52M | 202.05K | +15.28% | 49.88M |
| ASSENAGON ASSET MANAGEMENT S.A. | 1.13M | 221.37K | +24.41% | 36.92M |
| DIMENSIONAL FUND ADVISORS LP | 1.01M | 23.98K | +2.42% | 33.17M |
| POLAR CAPITAL HOLDINGS PLC | 833.72K | -298.80K | -26.38% | 27.28M |
| ECOR1 CAPITAL, LLC | 735.00K | 635.00K | +635.00% | 24.05M |
| MPM BIOIMPACT LLC | 723.31K | -43.72K | -5.70% | 23.67M |
| OPALEYE MANAGEMENT INC. | 700.00K | 0 | 0.00% | 22.90M |
| GOLDMAN SACHS GROUP INC | 575.34K | -255.36K | -30.74% | 18.83M |
Earnings and financials
Stoke Therapeutics, Inc. (STOK) trades at $26.25, with a market cap of $1.69B and a trailing P/E of -7.35. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 12405000 | 8780000 | 36555000 | 184420000 |
Insights · Dividends · Forecast · Financials · Learn